Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000179282 | SCV000852175 | pathogenic | Phenylketonuria | 2018-08-13 | reviewed by expert panel | curation | PAH-specific ACMG/AMP criteria applied: PVS1: Nonsense variant; PM2: ExAC MAF: 0.00010; PP4_Moderate: BH4 defect excluded in all patients in Liu 2015. Identified in 6 patients in this study (PMID:10394930; PMID:26600521); PM3_Strong: Identified in 6 patients, in trans with R243Q and R241C (both pathogenic) (PMID:26600521). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4_Moderate, PM3_Strong). |
Eurofins Ntd Llc |
RCV000088971 | SCV000231507 | pathogenic | not provided | 2014-08-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000179282 | SCV000629197 | pathogenic | Phenylketonuria | 2024-05-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg176*) in the PAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAH are known to be pathogenic (PMID: 1301187, 9634518). This variant is present in population databases (rs199475575, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with phenyketonuria (PMID: 8268925, 17935162, 23514811, 26413448, 26503515). ClinVar contains an entry for this variant (Variation ID: 102723). For these reasons, this variant has been classified as Pathogenic. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000179282 | SCV000696453 | pathogenic | Phenylketonuria | 2016-03-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000179282 | SCV000744099 | pathogenic | Phenylketonuria | 2014-10-08 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000179282 | SCV000745573 | pathogenic | Phenylketonuria | 2016-07-26 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000088971 | SCV000888349 | pathogenic | not provided | 2018-07-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000179282 | SCV000893951 | pathogenic | Phenylketonuria | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000179282 | SCV001810542 | pathogenic | Phenylketonuria | 2021-07-22 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV000179282 | SCV002573258 | pathogenic | Phenylketonuria | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Stop-gained (nonsense) is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 2 similarly affected unrelated individuals (PMID: 26600521). The variant has been reported multiple times as an established pathogenic variant (ClinVar ID: VCV000102723 / PMID: 8268925). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Baylor Genetics | RCV000179282 | SCV004201383 | pathogenic | Phenylketonuria | 2024-03-27 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV000179282 | SCV005418246 | pathogenic | Phenylketonuria | criteria provided, single submitter | clinical testing | PVS1+PM2_Supporting+PM3_VeryStrong | |
De |
RCV000088971 | SCV000119574 | not provided | not provided | no assertion provided | not provided | ||
Counsyl | RCV000179282 | SCV000485295 | pathogenic | Phenylketonuria | 2016-01-21 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000179282 | SCV001455097 | pathogenic | Phenylketonuria | 2020-09-16 | no assertion criteria provided | clinical testing |